Legacy Advisors’s AbbVie ABBV Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,983	Closed	-$4.61M	–	19
2025 Q1	$4.61M	Buy	21,983 +1,171	+6%	+$245K	0.47%	37
2024 Q4	$3.7M	Sell	20,812 -1,085	-5%	-$193K	0.36%	50
2024 Q3	$4.32M	Buy	21,897 +2,025	+10%	+$400K	0.47%	39
2024 Q2	$3.41M	Buy	19,872 +52	+0.3%	+$8.92K	0.41%	41
2024 Q1	$3.61M	Buy	19,820 +769	+4%	+$140K	0.46%	41
2023 Q4	$2.95M	Sell	19,051 -1,753	-8%	-$272K	0.38%	56
2023 Q3	$3.1M	Buy	20,804 +3,382	+19%	+$504K	0.5%	49
2023 Q2	$2.35M	Buy	17,422 +12,244	+236%	+$1.65M	0.35%	69
2023 Q1	$825K	Buy	5,178 +184	+4%	+$29.3K	0.15%	111
2022 Q4	$807K	Buy	4,994 +214	+4%	+$34.6K	0.15%	104
2022 Q3	$642K	Sell	4,780 -278	-5%	-$37.3K	0.14%	100
2022 Q2	$775K	Buy	5,058 +271	+6%	+$41.5K	0.16%	88
2022 Q1	$776K	Buy	4,787 +2,818	+143%	+$457K	0.15%	90
2021 Q4	$267K	Sell	1,969 -195	-9%	-$26.4K	0.1%	102
2021 Q3	$233K	Buy	2,164 +206	+11%	+$22.2K	0.09%	110
2021 Q2	$221K	Hold	1,958	–	–	0.09%	114
2021 Q1	$212K	Buy	+1,958	New	+$212K	0.09%	112
2019 Q3	–	Sell	-1,029	Closed	-$75K	–	113
2019 Q2	$75K	Sell	1,029 -27	-3%	-$1.97K	0.05%	181
2019 Q1	$85K	Buy	+1,056	New	+$85K	0.03%	166
2018 Q4	–	Sell	-2,322	Closed	-$220K	–	112
2018 Q3	$220K	Buy	2,322 +1,553	+202%	+$147K	0.11%	129
2018 Q2	$71K	Buy	769 +542	+239%	+$50K	0.05%	160
2018 Q1	$21K	Hold	227	–	–	0.02%	210
2017 Q4	$21K	Buy	227 +80	+54%	+$7.4K	0.02%	183
2017 Q3	$13K	Buy	+147	New	+$13K	0.01%	191